Listed

Burning Rock Biotech Ltd: Form 20-F for the period ended Dec 31, 2022

Filed with the SEC on Apr 20, 2023 and accepted by EDGAR at Apr 20, 2023, 16:01 ET.

Share

Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2022-12-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue12 months2022-01-01 to 2022-12-31$81.7mus-gaap:Revenues
Cost of revenue12 months2022-01-01 to 2022-12-31$26.6mus-gaap:CostOfRevenue
Gross profit12 months2022-01-01 to 2022-12-31$55.1mus-gaap:GrossProfit
Research and development12 months2022-01-01 to 2022-12-31$61.2mus-gaap:ResearchAndDevelopmentExpense
Operating income12 months2022-01-01 to 2022-12-31−$142.1mus-gaap:OperatingIncomeLoss
Income tax12 months2022-01-01 to 2022-12-31$288.0kus-gaap:IncomeTaxExpenseBenefit
Net income12 months2022-01-01 to 2022-12-31−$140.8mus-gaap:NetIncomeLoss
Operating cash flow12 months2022-01-01 to 2022-12-31−$66.2mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure12 months2022-01-01 to 2022-12-31$9.0mus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Cash and equivalentsAt period end2022-12-31$131.3mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2022-12-31$182.5mus-gaap:AssetsCurrent
Total assetsAt period end2022-12-31$230.2mus-gaap:Assets
Current liabilitiesAt period end2022-12-31$59.7mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2022-12-31$62.2mus-gaap:Liabilities
Short-term borrowingsAt period end2022-12-31$0us-gaap:ShortTermBorrowings
Shareholders' equityAt period end2022-12-31$167.9mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001193125-23-108289. Last ingested by Listed: Oct 24, 2026, 15:15 ET. Listed shows no prices and gives no investment advice.